Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Melanoma/Skin Cancer
What radiation dose-fractionation regimen would you choose for squamous cell carcinoma of the great toe in a patient who declines surgery?
How would you counsel the patient on wound healing and potential complications in this region?
Answer from: Radiation Oncologist at Community Practice
I've had good results with 35/5 QOD. 36 in 6, 2 fx a week is good, too. There is another similar thread: https://www.themednet.org/question/2647.
Sign in or Register to read more
20159
Related Questions
How would you approach a recurrent, cutaneous SCC of the face with high-risk features s/p resection?
In patients with Von Willebrand disease, who are presenting with cT1N0 SCC of the skin, what dose/fractionation is recommended?
How would you manage a Merkel cell carcinoma that spontaneously regressed clinically in a patient medically high-risk for surgical resection/anesthesia?
What is your preferred skin surface maximum dose constraint for skin brachytherapy?
How do you approach an elderly patient (~80 years) with stage IIC melanoma post resection with oligometastatic brain lesion post intracranial resection which developed 2 years after treatment?
How would you approach a patient with clinical T3N1 anorectal malignant melanoma referred by a surgeon for neoadjuvant therapy?
Would you consider adjuvant radiation for a patient with recurrent pelvic node melanoma s/p immunotherapy and pelvic lymph node dissection with complete pathological response (only necrotic tissue; no viable melanoma)?
What ENI/lymph node stations would you treat for a locally advanced SCC of the thumb?
For merkel cell carcinoma of the eyelid, how do you approach post-operative management and what are the recommended radiation treatment volumes?
What electron beam dose/fractionation would you use for a recurrence basal cell carcinoma of the scalp adjacent to a split thickness skin graft?